Victora C G, Bryce J, Fontaine O, Monasch R
Universidade Federal de Pelotas, RS Brazil.
Bull World Health Organ. 2000;78(10):1246-55.
In 1980, diarrhoea was the leading cause of child mortality, accounting for 4.6 million deaths annually. Efforts to control diarrhoea over the past decade have been based on multiple, potentially powerful interventions implemented more or less simultaneously. Oral rehydration therapy (ORT) was introduced in 1979 and rapidly became the cornerstone of programmes for the control of diarrhoeal diseases. We report on the strategy for controlling diarrhoea through case management, with special reference to ORT, and on the relationship between its implementation and reduced mortality. Population-based data on the coverage and quality of facility-based use of ORT are scarce, despite its potential importance in reducing mortality, especially for severe cases. ORT use rates during the 1980s are available for only a few countries. An improvement in the availability of data occurred in the mid-1990s. The study of time trends is hampered by the use of several different definitions of ORT. Nevertheless, the data show positive trends in diarrhoea management in most parts of the world. ORT is now given to the majority of children with diarrhoea. The annual number of deaths attributable to diarrhoea among children aged under 5 years fell from the estimated 4.6 million in 1980 to about 1.5 million today. Case studies in Brazil, Egypt, Mexico, and the Philippines confirm increases in the use of ORT which are concomitant with marked falls in mortality. In some countries, possible alternative explanations for the observed decline in mortality have been fairly confidently ruled out. Experience with ORT can provide useful guidance for child survival programmes. With adequate political will and financial support, cost-effective interventions other than that of immunization can be successfully delivered by national programmes. Furthermore, there are important lessons for evaluators. The population-based data needed to establish trends in health service delivery, outcomes and impact are not available in respect of diarrhoea, as is true for malaria, pneumonia and other major childhood conditions. Standard indicators and measurement methods should be established. Efforts to change existing global indicators should be firmly resisted. Support should be given for the continuing evaluation and documentation activities needed to guide future public health policies and programmes.
1980年,腹泻是儿童死亡的主要原因,每年导致460万人死亡。在过去十年中,控制腹泻的努力基于多种可能有效的干预措施,这些措施或多或少同时实施。口服补液疗法(ORT)于1979年引入,并迅速成为腹泻病控制项目的基石。我们报告通过病例管理控制腹泻的策略,特别提及口服补液疗法,以及其实施与死亡率降低之间的关系。尽管口服补液疗法在降低死亡率方面具有潜在重要性,尤其是对重症病例,但基于人群的关于医疗机构使用口服补液疗法的覆盖率和质量的数据却很匮乏。20世纪80年代只有少数几个国家有口服补液疗法的使用率数据。20世纪90年代中期数据的可得性有所改善。由于对口服补液疗法使用了几种不同的定义,时间趋势研究受到了阻碍。尽管如此,数据显示世界上大多数地区在腹泻管理方面呈现积极趋势。现在大多数腹泻儿童都接受了口服补液疗法。5岁以下儿童中每年因腹泻导致的死亡人数从1980年估计的460万降至如今的约150万。巴西、埃及、墨西哥和菲律宾的案例研究证实了口服补液疗法使用的增加与死亡率的显著下降同时出现。在一些国家,已相当有把握地排除了对观察到的死亡率下降的其他可能解释。口服补液疗法的经验可为儿童生存项目提供有益指导。有了足够的政治意愿和财政支持,国家项目可以成功实施除免疫接种之外具有成本效益的干预措施。此外,对评估人员来说也有重要的经验教训。与疟疾、肺炎和其他主要儿童疾病一样,腹泻方面缺乏用于确立卫生服务提供、结果和影响趋势所需的基于人群的数据。应建立标准指标和测量方法。应坚决抵制改变现有全球指标的努力。应支持进行持续评估和记录活动,以指导未来的公共卫生政策和项目。